February 6, 2025 - 16:54

Recent research highlights a concerning trend in global mental health care, revealing that merely 6.9 percent of individuals suffering from mental health or substance-use disorders receive effective treatment. This statistic underscores a significant gap in the accessibility and quality of care available to those in need.
The findings suggest that a vast majority of individuals grappling with these disorders remain untreated, leading to severe consequences not only for their well-being but also for society at large. Factors contributing to this crisis include stigma, lack of resources, and insufficient mental health infrastructure in many regions.
Experts emphasize the urgent need for improved mental health services and increased investment in treatment options. By addressing these barriers, it is possible to enhance the quality of life for millions and reduce the overall burden of mental health disorders on healthcare systems. The call for action is clear: more must be done to ensure that effective care reaches those who desperately need it.
May 13, 2026 - 19:53
From Zambia to Harvard: How Chimba Sanga Is Fighting HIV and TB With New SkillsChimba Sanga, a physician and public health leader from Zambia, is bringing his Harvard training back home to tackle two of the country`s deadliest diseases. Sanga, currently a Master of Public...
May 13, 2026 - 01:07
AP report: Marty Makary resigning as Trump's FDA chiefMarty Makary is resigning as head of the Food and Drug Administration, according to an Associated Press report. His departure comes after a turbulent tenure marked by deep internal discord and a...
May 12, 2026 - 10:26
Shortage of beds, staff force Michigan kids out of state for mental health treatmentMichigan children facing severe mental health crises are increasingly being transported out of state for treatment, sometimes traveling thousands of miles away from their families. The root cause...
May 11, 2026 - 17:47
Medicare’s miss on Alzheimer’s drug spendingFar fewer seniors than expected are taking costly Alzheimer`s drugs, leaving Medicare spending well below earlier government forecasts. The new class of amyloid-targeting treatments, including...